Synaptic degeneration in rat brain after prolonged oral exposure to silver nanoparticles

NeuroToxicology

Volumn 46, Issue , 2015, Pages 145-154

  Skalska, Joanna ^a   Frontczak Baniewicz, Małgorzata ^a   Struzyńska, Lidia ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Myelin like bodies; Nanotoxicity; PSD 95; Synapsin I; Synaptophysin

Indexed keywords

POSTSYNAPTIC DENSITY PROTEIN 95; SILVER NANOPARTICLE; SYNAPSIN I; SYNAPTOPHYSIN; DLGH4 PROTEIN, RAT; MEMBRANE PROTEIN; NANOPARTICLE; SIGNAL PEPTIDE; SILVER DERIVATIVE; SYNAPSIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; HIPPOCAMPUS; IN VIVO STUDY; MALE; NERVE DEGENERATION; NEUROPIL; NEUROTOXICITY; NONHUMAN; POSTSYNAPTIC DENSITY; RAT; SYNAPSE VESICLE; SYNAPTIC DEGENERATION; SYNAPTIC MEMBRANE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ELECTRON TOMOGRAPHY; GENE EXPRESSION REGULATION; MASS SPECTROMETRY; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; SYNAPSE; TIME; ULTRASTRUCTURE; WISTAR RAT;

RATTUS;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON MICROSCOPE TOMOGRAPHY; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MASS SPECTROMETRY; MEMBRANE PROTEINS; NANOPARTICLES; NERVE DEGENERATION; RATS; RATS, WISTAR; SILVER COMPOUNDS; SYNAPSES; SYNAPSINS; SYNAPTOPHYSIN; TIME FACTORS;

EID: 84923011007     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.11.002     Document Type: Article

References (62)

1. AshaRani P.V., Mun G.L.K., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
2. Bidgoli S.A., Mahdavi M., Rezayat S.M., Korani M., Amani A., Ziarati P. Toxicity assessment of nanosilver wound dressing in Wistar rat. Acta Med Iran 2013, 51:203-208.
3. Blaser S.A., Sheringer M., Macleod M., Hungerbuhler K. Estimation of cumulative aquatic exposure and risk due to silver: contribution of nanofunctionalized plastics and textiles. Sci Total Environ 2008, 390:396-409.
4. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008, 176:1-12.
5. Chen D., Xi T., Bai J. Biological effects induced by nanosilver particles: in vivo study. Biomed Mater 2007, 2:S126-S128.
6. Christen V., Capelle M., Fent K. Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish. Toxicol Appl Pharmacol 2013, 272:519-528.
7. Christensen F.M., Johnston H.J., Stone V., Aitken R.J., Hankin S., Peters S., et al. Nano-silver - feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 2010, 4:284-295.
8. Christian P., Von der Kammer F., Baalousha M., Hofmann T.H. Nanoparticles: structure, properties preparation and behaviour in environmental media. Ecotoxicology 2008, 17:326-343.
9. Cushen M., Kerry J., Morris M., Cruz-Romero M., Cummins E. Evaluation and simulation of silver and copper nanoparticle migration from polyethylene nanocomposites to food and an associated exposure assessment. J Agric Food Chem 2014, 62:1403-1411.
10. Dawson G.R., Seabrook G.R., Zheng H., Smith D.W., Graham S., O'Dowd G., et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 1999, 90:1-13.
11. De Camilli T.P., Greengard P., Synapsin I. A synaptic-vesicle associated neuronal phosphoprotein. Biochem Pharmacol 1986, 35:43-49.
12. Eom H-J., Ahn J-M., Kim Y., Choi J. Hypoxia inducible factor-1 (HIF-1)-flavin containing monooxygenase-2 (FMO-2) signaling acts in silver nanoparticles and silver ion toxicity in the nematode, Caenorhabditis elegans. Toxicol Appl Pharmacol 2013, 270:106-113.
13. Espinosa-Cristobal L.F., Martinez-Castañon G.A., Loyola-Rodriguez J.P., Patiño-Marin N., Reyes-Macías J.F., Vargas-Morales J.M., et al. Toxicity, distribution, and accumulation of silver nanoparticles in Wistar rats. J Nanopart Res 2013, 15:1702.
14. Fabrega J., Luoma S.N., Tyler C.R., Galloway T.S., Lead J.R. Silver nanoparticles: behaviour and effects in the aquatic environment. Environ Int 2011, 37:517-531.
15. Foldbjerg R., Olesen P., Hougaard M., Dang D.A., Hoffmann H.J., Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009, 190:156-162.
16. Greengard P., Valtorta F., Czernik A.J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993, 259:780-785.
17. Haase A., Rott S., Mantion A., Graf P., Plendl J., Thünemann A.F., et al. Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses. Toxicol Sci 2012, 126:457-468.
18. Hadrup N., Lam H.R. Oral toxicity of silver ions, silver nanoparticles and colloidal silver - a review. Regul Toxicol Pharmacol 2014, 68:1-7.
19. Hadrup N., Loeschner K., Mortensen A., Sharma A.K., Qvortrup K., Larsen E.H., et al. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology 2012, 33:416-423.
20. Hoet P.H., Brüske-Hohlfeld I., Salata O.V. Nanoparticles - known and unknown health risks. J Nanobiotechnol 2004, 2:12.
21. Kelekar A. Autophagy. Ann N Y Acad Sci 2005, 1066:259-271.
22. Keith D., El-Husseini A. Excitation control: balancing PSD-95 function at the synapse. Front Mol Neurosci 2008, 1:4.
23. Kubik T., Bogunia-Kubik K., Sugisaka M. Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 2005, 6:17-33.
24. Lankveld D.P., Oomen A.G., Krystek P., Neigh A., Troost-de Jong A., Noorlander C.W., et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010, 31:8350-8361.
25. Lee J.H., Kim Y.S., Song K.S., Ryu H.R., Sung J.H., Park J.D., et al. Biopersistence of silver nanoparticles in tissues from Sprague Dawley rats. Part Fibre Toxicol 2013, 10:36.
26. Lee T.Y., Liu M.S., Huang L.J., Lue S.I., Lin L.C., Kwan A.L., et al. Bioenergetic failure correlates with autophagy and apoptosis in rat liver following silver nanoparticle intraperitoneally administration. Part Fibre Toxicol 2013, 10:40.
27. Li L., Chin L.S., Shupliakov O., Brodin L., Sihra T.S., Hvalby O., et al. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. Proc Natl Acad Sci U S A 1995, 92:9235-9239.
28. Liu J., Hurt R.H. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 2010, 44:2169-2175.
29. Loeschner K., Hadrup N., Qvortru K., Larsen A., Gao X., Vogel U., et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 2011, 8:18.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 19:265-275.
31. Lubick N. Nanosilver toxicity: ions, nanoparticles-or both?. Environ Sci Technol 2008, 42:8617.
32. Marambio-Jones C., Hoek E.M.V. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 2010, 12:1531-1551.
33. Masliah E. Recent advances in the understanding of the role of synaptic proteins in Alzheimer's disease and other neurodegenerative disorders. J Alzheimers Dis 2001, 3:121-129.
34. Masliah E., Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 1993, 3:77-85.
35. McNeill T.H., Brown S.A., Rafols J.A., Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988, 455:148-152.
36. Meyer J.N., Lord C.A., Yang X.Y., Turner E.A., Badireddy A.R., Marinakos S.M., et al. Intracellular uptake and associated toxicity of silver nanoparticles in Caenorhabditis elegans. Aquat Toxicol 2010, 100:140-150.
37. Miethling-Graff R., Rumpker R., Richter M., Verano-Braga T., Kjeldsen F., Brewer J., et al. Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol In Vitro 2014, 28:1280-1289.
38. Oberdörster G., Elder A., Rinderknecht A. Nanoparticles and the brain: cause for concern. J Nanosci Nanotechnol 2009, 9:4996-5007.
39. Osborne O.J., Johnston B.D., Moger J., Balousha M., Lead J.R., Kudoh T., et al. Effects of particle size and coating on nanoscale Ag and TiO, exposure in zebrafish (Danio rerio) embryos. Nanotoxicology 2013, 7:1315-1324.
40. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, Sydney, AU.
41. Piao M.J., Kang K.A., Lee I.K., Kim H.S., Kim S., Choi J.Y., et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011, 201:92-100.
42. Pratsinis A., Hervella P., Leroux J.C., Pratsinis S.E., Sotiriou G.A. Toxicity of silver nanoparticles in macrophages. Small 2013, 9:2576-2584.
43. Rahman M.F., Wang J., Patterson T.A., Saini U.T., Robinson B.L., Newport G.D., et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 2009, 187:15-21.
44. Rao J.S., Kellom M., Kim H.W., Rapoport S.I., Reese E.A. Neuroinflammation and synaptic loss. Neurochem Res 2012, 37:903-910.
45. Saggu S.K., Chotaliya H.P., Blumbergs P.C., Casson R.J. Wallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study. BMC Neurosci 2010, 11:97.
46. Sharma H.S., Ali S.F., Hussain S.M., Schlager J.J., Sharma A. Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol 2009, 9:5055-5072.
47. Sharma H.S., Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog Brain Res 2007, 162:245-273.
48. Schuettauf F., Rejdak R., Walski M., Frontczak-Baniewicz M., Voelker M., Blatsios G., et al. Retinal neurodegeneration in the DBA/2 J mouse - a model for ocular hypertension. Acta Neuropathol 2004, 107:352-358.
49. Scown T.M., Santos E.M., Johnston B.D., Gaiser B., Baalousha M., Mitov S., et al. Effects of aqueous exposure to silver nanoparticles of different sizes in rainbow trout. Toxicol Sci 2010, 115:521-534.
50. Struzynski W., Dabrowska-Bouta B., Grygorowicz T., Zieminska E., Struzynska L. Markers of oxidative stress in hepatopancreas of crayfish (Orconectes limosus, raf.) experimentally exposed to nanosilver. Environ Toxicol 2014, 29:1283-1291.
51. Tang J., Xiong L., Wang S., Wang J., Liu L., Li J., et al. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 2009, 9:4924-4932.
52. Valtorta F., Tarelli F.T., Campanati L., Villa A., Greengard P. Synaptophysin and synapsin I as tools for the study of the exo-endocytotic cycle. Cell Biol Int Rep 1989, 13:1023-1038.
53. Van der Zande M., Vandebriel R.J., Van Doren E., Kramer E., Herrera Rivera Z., Serrano-Rojero C.S., et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6:7427-7442.
54. Wagner V., Dullaart A., Bock A.K., Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006, 24:1211-1217.
55. Wegner C., Esiri M.M., Chance S.A., Palace J., Matthews P.M. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006, 67:960-967.
56. Wu Y., Zhou Q. Silver nanoparticles cause oxidative damage and histological changes in medaka (Oryzias latipes) after 14 days of exposure. Environ Toxicol Chem 2013, 32:165-173.
57. Xu F., Piett C., Farkas S., Qazzaz M., Syed N.I. Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons. Mol Brain 2013, 6:29.
58. Yamagata Y. New aspects of neurotransmitter release and exocytosis: dynamic and differentia regulation of synapsin I phosphorylation by acute neuronal excitation in vivo. J Pharmacol Sci 2003, 93:22-29.
59. Yang Z., Liu Z.W., Allaker R.P., Reip P., Oxford J., Ahmad Z., et al. A review of nanoparticle functionality and toxicity on the central nervous system. J R Soc Interface 2010, 7(Suppl. 4):S411-S422.
60. Yin L.Y., Cheng Y.W., Espinasse B., Colman B.P., Auffan M., Wiesner M., et al. More than the ions: the effects of silver nanoparticles on Lolium multiflorum. Environ Sci Technol 2011, 45:2360-2367.
61. Yin N., Liu Q., Liu J., He B., Cui L., Li Z., et al. Silver nanoparticle exposure attenuates the viability of rat cerebellum granule cells through apoptosis coupled to oxidative stress. Small 2013, 9:1831-1841.
62. Zieminska E., Stafiej A., Struz˙yńska L. The role of the glutamatergic NMDA receptor in nanosilver-evoked neurotoxicity in primary cultures of cerebellar granule cells. Toxicology 2014, 315:38-48.